Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 280 results for "Byetta"

Byetta Lawsuit News: Federal Incretin Mimetic Litigation Adds 30 Cases...
PRWeb

Byetta Lawsuit News: Federal Incretin Mimetic Litigation Adds ...

The Firm is actively evaluating Byetta lawsuit claims on behalf of diabetics who allegedly developed pancreatitis, pancreatic cancer or thyroid cancer after taking the incretin mimetic. More than 30 federal cases have joined a federal diabetes drug ... PRWeb, 2 days ago
[x]  

10 images for Byetta

Virtual Strategy Magazine, 2 days ago
Virtual Strategy Magazine, 3 weeks ago
PRWeb, 1 month ago
PR inside, 2 months ago
PRWeb, 3 months ago
ABC News 4 Charleston, 4 months ago
Scottrade, 4 months ago
PRWeb, 5 months ago
PRWeb, 5 months ago
Lawyers & Settlements, 5 months ago

10 images for Byetta

Logo
Virtual Strategy Magazine, 2 days ago

Byetta Pancreatic Cancer Allegations Lawyer Help: Resource4thePeople Notes Increase in Federal Multidistrict Litigation Lawsuits

National network of lawyers continues offer of complimentary consultations to consumers seeking compensation in lawsuits alleging links between diabetes medications Byetta, Januvia, Janumet and Victoza and pancreatic cancer.
 PRWeb1 month ago Januvia Pancreatic Cancer Allegations Help: Resource4thePeople Following Increase in Number of Consolidated Federal Cases  Digital Journal1 month ago
[x]  
EMax Health

US eases concern about certain diabetes drugs

People who take Januvia, Byetta or certain other widely prescribed medicines for diabetes can breathe a little easier U.S. and European regulators have found no compelling evidence of a link between these drugs and pancreas problems or pancreatic ...
 Malta Independent Daily1 month ago FDA eases concern about certain diabetes drugs  Miami Herald1 month ago Newly minted GlaxoSmithKline diabetes drug faces formidable foes in GLP-1 market  FiercePharma3 days ago FDA to review empagliflozin/linagliptin tablet for treating type 2 diabetes  Orthopedics Today3 days ago
[x]  
PRWeb

As Byetta Lawsuit Filings Mount, Bernstein Liebhard LLP Notes New Study That Raises Questions About the Costs and Benefits of Newer Diabetes Drugs

As Byetta lawsuits (http://www.byettalawsuit.com) continue to move forward in federal court, Bernstein Liebhard LLP notes that a newly published study is raising questions about the costs and benefits associated with newer medications used in the ...
 Digital Journal3 weeks ago Byetta Lawsuit Filings Move Forward in Federal Litigation Housing More than 300 Diabetes Drug Cases, Bernstein Liebhard LLP Reports  Digital Journal1 month ago Byetta Lawsuit Plaintiff Withdraws Motion Seeking Consolidation of Federal Byetta Thyroid Cancer Claims, Bernstein Liebhard LLP Reports  Digital Journal1 month ago Byetta Lawsuit Update: Court Considering Case Management Proposals in...  PRWeb2 months ago
[x]  
PRWeb

Byetta Lawsuit News: More than 320 Cases Filed in Federal Incretin Mimetic Litigation One Year after FDA Safety Alert, Bernstein Liebhard LLP Reports

A year after the U.S. Food and Drug Administration (FDA) publicly vowed to investigate the safety of a drug now involved in Byetta lawsuit (http://www.byettalawsuit.com/) filings, as well as several other Type 2 diabetes medications, court documents ...
 Digital Journal4 weeks ago
[x]  

AdverseEvents' Special Report: Examining the Comparative Safety of Type 2 Diabetes Drugs

Type 2 Diabetes Drugs Safety Review: Byetta Has Best Safety Profile, Nesina Shows Worst Safety Profile Type 2 Diabetes affects approximately 230 million people worldwide and incidence is growing at an alarming rate. To address this epidemic, new ...
 FiercePharma3 days ago Research and Markets Adds Report: Global Type 2 Diabetes Therapeutics Market 2013-2019  Individual.com5 days ago Global Type 2 Diabetes Therapeutics Market 2013-2019  Individual.com1 week ago Research and Markets: Global Type 2 Diabetes Therapeutics Market 2013-2019  TMC Net1 week ago
[x]  
Pharma Letter

Clock Is Ticking For AstraZeneca

thought Victoza would do ok until Bydureon came along as Victoza is a once-daily injection compared to Byetta which is injected twice-daily and was the only approved GLP-1 back when Victoza came
 Big News Network1 month ago DURATION-3: Weekly exenatide shows promise for type 2 diabetes  Orthopedics Today1 week ago Researchers Submit Patent Application, "Methods for Administering Long-Lasting Hypoglycemic Agents", for Approval  4 Traders1 month ago 3/17/14 - U.S. FDA Approves Bydureon® Pen exenatide extended-release for injectable suspension for Once-Weekly Treatment of Adults with Type 2 Diabetes  Pharmacy Choice1 month ago
[x]  

AstraZeneca Q1 earnings preview

AstraZeneca reports 1Q14 results on Thursday 24th April 08.00 CEST We forecast 1Q14 sales of $6,329 (+2% in LC, our forecast are -0.7% below company collected cons.e at $6,373m). We forecast core operating profit of $2,009m (-1.8% vs cons.e at ...
 Invezz3 days ago

New report finds Bydureon safest of new class of diabetes drugs

Analysis of FDA adverse event data tries to pull together risks of three new classes of drugs Share Tools Bydureon--Courtesy of AstraZeneca With big money to be made, drugmakers have responded to the global rise in Type 2 diabetes with a ...
 FiercePharma3 days ago Report: Newer Diabetes Drugs Cost More, But May Not Work Better  P&T Community1 month ago New Diabetes Treatments May be Ineffective  Cutting Edge News1 month ago
Jutia Group

FDA finally OKs GlaxoSmithKline's Tanzeum to treat type 2 diabetes

UK pharma giant GlaxoSmithKline (LSE: GSK) yesterday received the much anticipated approval from the US Food and Drug Administration for its Tanzeum (albiglutide), for subcutaneous use, as a once-weekly treatment for type 2 diabetes. Tanzeum has ...
 Pharma Letter4 days ago FDA approves GSK's Tanzeum to treat type 2 diabetes  CNBC4 days ago Company Update (NYSE:BMY): Bristol-Myers Squibb Submits New Drug Application to U.S. FDA for a Fixed-Dose Combination Tablet of Atazanavir Sulfate with Cobicistat for People Living with HIV-1  Jutia Group5 days ago FDA approves Tanzeum to treat type 2 diabetes  FOXNews.com4 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - Byetta
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less